VYNE Therapeutics
VYNE
#9390
Rank
โ‚ฌ37.82 M
Marketcap
2,56ย โ‚ฌ
Share price
-4.93%
Change (1 day)
-30.08%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -10,47ย โ‚ฌ

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -10,48ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -6,96ย โ‚ฌ an increase over its 2021 EPS that were of -24,62ย โ‚ฌ.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-10,47ย โ‚ฌ50.45%
2022-6,96ย โ‚ฌ-71.72%
2021-24,62ย โ‚ฌ-84.19%
2020-155,73ย โ‚ฌ-26.29%
2019-211,28ย โ‚ฌ28.75%
2018-164,10ย โ‚ฌ10.79%
2017-148,12ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,07ย โ‚ฌ-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA